Skip to main content
. 2020 Mar 3;34(2):479–488. doi: 10.21873/invivo.11798

Figure 4. Forest plot of comparison between gemcitabine (Gem)-based chemotherapy (CHT) plus anti-epidermal growth factor receptor (EGFR) versus gemcitabine-based chemotherapy alone; the outcome was hazard ratio of overall survival. CI: Confidence intervaI.

Figure 4